GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology: GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/glaxosmithkline-sues-pfizer-biontech-over-covid-19-vaccine-technology-2024-04-25/
GSK readies for pivotal ruling in Zantac cases: Judge to decide on admission of evidence as part of litigation that has knocked billions off pharma group’s value ...
ft.com/content/ca0b53b0-8025-4d12-a496-f4d527b13953
Dawn Business : Considered to be one of the first cases in the history of Pakistan, the Rawalpindi Drug Court has awarded imprisonment and heavy fines to the CEO and ... Show more
Drug court hands down prison terms, fines in rare verdict - Newspaper - DAWN.COM
Drug court hands down prison terms, fines in rare verdict - Newspaper - DAWN.COM
GSK Addresses the Needs in Vaccination for Older Adults: Dive into the Adult Vaccination Landscape and Impact of Preventative Care in Malaysia
malaysiakini.com/brandedcontent/703664
Is the Shingles Vaccine Worthwhile? : If you were vaccinated against shingles pre-2020, you received a product called Zostavax. The new vaccine on the scene ...
health.clevelandclinic.org/which-vaccine-can-best-protect-me-against-shingles
AstraZeneca will cap inhaler costs at $35 per month: The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device ...
washingtonpost.com/business/2024/03/18/astrazeneca-inhaler-price-cap/
Quick Glance: AstraZeneca caps out-of-pocket costs for inhalers
- AstraZeneca announced it will cap out-of-pocket costs for inhaled respiratory products in the US at $35 per month, following a similar move by rival Boehringer Ingelheim.
- This decision comes amidst increasing political scrutiny of high drug prices in the US, particularly for inhalers used to treat asthma and chronic obstructive pulmonary disease.
- The out-of-pocket cost cap will be effective from June 1 for AstraZeneca's entire respiratory product portfolio, including popular inhalers like Airsupra, Bevespi Aerosphere, and Breztri Aerosphere.
- AstraZeneca CEO Pascal Soriot emphasized the need for comprehensive healthcare reform to ensure patients can afford essential medications.
Asthma Inhaler Chaos Leaves Us Doctors and the Children We Treat Out of Breath: The go-to asthma inhaler prescribed by pediatricians for decades has been ...
usnews.com/opinion/articles/2024-04-18/asthma-inhaler-chaos-leaves-us-doctors-and-the-children-we-treat-out-of-breath
Pfizer wants the first FDA approval ever for an RSV vaccine for young adults: There is currently no approved RSV vaccine for adults 18-59 years old
qz.com/pfizer-rsv-younger-adults-18-59-fda-approval-1851397604
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.
barrons.com/articles/pfizer-fda-rsv-vaccine-shot-gsk-moderna-4b1d50cc
Paid articlePaid
GSK settles another lawsuit on heartburn drug Zantac in California: GSK agreed to confidentially settle another lawsuit in California that had alleged its ...
reuters.com/legal/gsk-confidentially-settles-another-california-zantac-lawsuit-2024-02-29/
UK Risks Critical Medicine Shortage as EU Lures Drugmakers, Sandoz Says: Britain risks running out of critical medicines because it’s failing to stay competitive ...
bloomberg.com/news/articles/2024-03-22/uk-risks-critical-medicine-shortage-as-eu-lures-drugmakers
Paid articlePaid
Massive TB vaccine trial starts in SA – could deliver first new jab in over a century
dailymaverick.co.za/article/2024-03-19-massive-tb-vaccine-trial-starts-in-sa-could-deliver-first-new-jab-in-over-a-century/
GSK settles another Zantac lawsuit in California: GSK (GSK.L) said on Thursday it had agreed to settle another lawsuit in California that alleged its ...
reuters.com/business/healthcare-pharmaceuticals/gsk-confidentially-settles-another-zantac-lawsuit-california-2024-02-01/
GlaxoSmithKline Egypt concluded 2023 with significant sales leap, exceeding two billion pounds, a 23% increase over the previous year ...
english.ahram.org.eg/NewsContent/3/14/518848/Business/Markets--Companies/GlaxoSmithKline-Egypt-concluded--with-significant-.aspx
Parents scramble as common children's asthma med disappears: Senator Elizabeth Warren on Friday accused the drug's manufacturer, GlaxoSmithKline ...
bostonglobe.com/2024/03/03/metro/asthma-flovent-glaxo-smith-kline-children-warren/
RSV vaccination: US authorities report possible small increase in Guillain-Barré syndromes
aerzteblatt.de/nachrichten/149715/RSV-Impfung-US-Behoerden-melden-moeglichen-geringen-Anstieg-von-Guillain-Barre-Syndromen
How Often Do You Need an RSV Shot? A CDC Call Has High Stakes for GSK, Moderna.: The agency’s vaccine advisory committee could offer clues about an eventual call ...
barrons.com/articles/gsk-moderna-stock-rsv-vaccines-26e5f86b
Paid articlePaid
A dispute over a common asthma drug leaves patients caught in the middle: The most common asthma inhaler for children was discontinued at the start of this year ...
thehill.com/policy/healthcare/4472283-a-dispute-over-a-common-asthma-drug-leaves-patients-caught-in-the-middle/
Bernie Sanders, Senate Democrats open investigation into price of asthma inhalers
cnn.com/2024/01/08/health/senate-democrats-investigate-price-of-asthma-inhalers/
GSK Reports Earnings Wednesday. Investors Are Watching the RSV Vaccine Showdown.: GSK reports earnings Wednesday in a week week for pharmaceutical companies’ ...
barrons.com/articles/gsk-earnings-stock-price-98e16db2
Paid articlePaid
A popular asthma inhaler is leaving pharmacy shelves. Here's what you need to know
npr.org/sections/health-shots/2023/12/30/1222224197/a-popular-asthma-inhaler-is-leaving-pharmacy-shelves-heres-what-you-need-to-know
According to STIKO: New vaccination recommendation against meningococcal B: The Standing Vaccination Commission now recommends vaccinations against meningococcal ...
instyle.de/mini-me/laut-stiko-neue-impfempfehlung-gegen-meningokokken-b
What do you think of our best companies list for January?
🍽️ Yum China $YUMC
🚬 Imperial Brands $IMBBY
💊 GSK $GSK
💉 Pfizer $PFE
🏥 Zimmer Biomet $ZBH
🍲 Campbell ... Show more
How to prevent shingles and what to do if you get it: Shingles can be painful, itchy and have long-term side effects. Here’s what to know about preventing and ...
washingtonpost.com/wellness/2024/01/15/shingles-shingrix-vaccine-chickenpox/
Delisting: SEC, court okay GSK share buyback: This was revealed in a notice filed with the Nigerian Exchange Limited on Thursday.
punchng.com/delisting-sec-court-okay-gsk-share-buyback/
GSK's blood cancer drug meets primary goal in late-stage trial: GSK (GSK.L) said on Monday that its blood cancer drug Blenrep had reached a key goal in a ...
reuters.com/business/healthcare-pharmaceuticals/gsk-says-blood-cancer-drug-meets-primary-goal-late-stage-trial-2023-11-27/
LIVE: Reuters Newsmaker with Emma Walmsley, CEO of GlaxoSmithKline: Reuters Live on X (Twitter)
twitter.com/i/broadcasts/1MYxNoamwVpKw
Mother and baby home redress scheme to open in first three months of 2024: The scheme had initially been expected to open before the end of 2023
irishexaminer.com/news/arid-41290492.html
WHO prequalifies a second malaria vaccine, a significant milestone in the prevention of the disease
thedailystar.net/star-health/news/who-prequalifies-second-malaria-vaccine-significant-milestone-the-prevention-the-disease-3512886
Flovent Inhalers Discontinued—Here's What People With Asthma Should Know: Drug manufacturer GSK has discontinued Flovent asthma inhaler in favor of generics ...
health.com/flovent-asthma-inhalers-switch-to-generic-8421810
Why an inhaler switch has pediatricians worried about kids' health: A drugmaker's decision to swap its product for a cheaper generic underscores the challenge of ...
axios.com/2024/01/03/asthma-inhaler-discontinued-gsk
Popular corticosteroid asthma inhaler Flovent was discontinued this month: A new “authorized generic” version will be available in its place, but experts worry ...
popsci.com/health/lovent-discontinued-january-2024/
Remembering when Ribena was exposed by teens Jenny Suo and Anna Devathasan: Blackcurrant drink Ārepa has faced recent scrutiny over the claims made on its label ...
nzherald.co.nz/nz/remembering-when-ribena-was-exposed-by-teens-jenny-suo-and-anna-devathasan/NGA3CF3KOJFZTH6B53TIX2LSIQ/
Obi Laments Multinational Companies' Exit, Says Nigeria's Investment Profile Not Attractive
The Labour Party presidential candidate in the 2023 elections ... Show more
What It’s Like to Have RSV as an Older Adult: This grandfather’s story may move you to take steps to help protect yourself from respiratory syncytial virus (RSV) ...
prevention.com/health/health-conditions/a44306218/what-its-like-to-have-rsv-as-an-older-adult/
A committee of the European health regulator on Friday confirmed its initial recommendation to not renew conditional market approval for GSK's Blenrep, citing recent data that did not confirm the blood cancer drug's effectiveness.
reut.rs/3RIoIG6
EU regulator backs GSK's bone marrow cancer therapy: British drugmaker GSK (GSK.L) on Monday said the human medicines committee of the European Medicines Agency ...
reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-gsks-bone-marrow-cancer-therapy-2023-11-13/
Astra, GSK, AbbVie Accused by Senator Warren of 'Abusing' Drug Patent System
bloomberg.com/news/articles/2023-12-14/astra-abbvie-slammed-by-warren-for-abusing-drug-patent-system
European shares edge up on retail, healthcare boost; Fed decision eyed: Europe's benchmark index rose marginally on Wednesday, led by healthcare and retail ...
reuters.com/markets/europe/european-shares-hit-two-week-high-healthcare-boost-fed-rate-verdict-eyed-2023-11-01/
How can you be a better leader? On “Boss Class”:
🎧 Emma Walmsley, CEO of @GSK 🎧 Nobel prize-winning psychologist, @kahneman_daniel 🎧 Former COO of Stripe ... Show more
@chughesjohnson
econ.st/473tDX2
@chughesjohnson
econ.st/473tDX2
More than 330,000 doses of WHO-recommended RTS,S malaria vaccine arrived in Cameroon last night - a historic step towards broader vaccination against one of ... Show more
GSK settles another California lawsuit on heartburn drug Zantac: GSK (GSK.L) on Wednesday said it agreed to settle another lawsuit in California alleging its ...
reuters.com/legal/gsk-reaches-confidential-settlement-california-zantac-lawsuit-2023-10-11/
US FDA approves Pfizer's vaccine for meningococcal disease: The U.S. Food and Drug Administration (FDA) has approved Pfizer's (PFE.N) vaccine Penbraya ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-vaccine-meningococcal-diseases-2023-10-20/
Hong Kong’s private healthcare providers expected to offer RSV vaccine from mid-December, but experts say more data needed to decide if public sector should ...
scmp.com/news/hong-kong/health-environment/article/3242080/hong-kongs-private-healthcare-providers-expected-offer-rsv-vaccine-mid-december-experts-say-more
Malaria vaccine big advance against major child killer: Deals are in place to make 100 million doses of the vaccine each year to fight the complex disease.
bbc.com/news/health-66985273
Drugmakers plan to pay $20M for DNA from 23andMe customers: GSK Plc is extending a five-year collaboration that’s allowed the drugmaker to mine genetic data as ...
nationalpost.com/news/drugmakers-plan-to-pay-20m-for-dna-from-23andme-customers
Fewer and fewer pharmacies and too few medicines: The number of pharmacies continues to decrease, and some medicines also become rare as the cold season begins - ...
ptaheute.de/aktuelles/2023/11/03/immer-weniger-apotheken-und-zu-wenig-arzneimittel
Stock market: This is what moves the DAX before the Fed meeting - Zalando and AMD shares in focus
boerse-online.de/nachrichten/rohstoffe/boerse-so-verhaelt-sich-der-dax-vor-der-fed-sitzung-aktien-von-gsk-und-amd-im-fokus-20342436.html
23andMe Will Give GSK Access to Consumer DNA Data: GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data
Scynexis to recall GSK-partnered antifungal on cross contamination risk: Scynexis (SCYX.O) said on Monday it would voluntarily recall its antifungal pill ...
reuters.com/business/healthcare-pharmaceuticals/scynexis-recall-antifungal-market-pause-studies-2023-09-25/
US FDA approves GSK's bone marrow cancer therapy: (This Sept. 15 story has been corrected show that momelotinib is approved for patients regardless of prior ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-gsks-anemia-treatment-2023-09-15/
Sudan conflict: US imposes sanctions on two companies, Sudans former minister over instability
wionews.com/world/sudan-conflict-us-imposes-sanctions-on-two-companies-sudans-former-minister-over-instability-640704
European Commission authorises GSK's HIV prevention drug: The European Commission has authorised GSK's (GSK.L) HIV-focused unit ViiV Healthcare's cabotegravir ...
reuters.com/business/healthcare-pharmaceuticals/european-commission-authorises-gsks-hiv-prevention-drug-2023-09-19/
How new malaria vaccine will work: The Health ministry has said the country is considering the new malaria vaccine, which the World Health Organisation has ...
monitor.co.ug/uganda/news/national/how-new-malaria-vaccine-will-work-4389316
Pfizer (PFE) and GSK's New RSV Vaccines On Track For $2 Billion in Sales: GSK Plc and Pfizer Inc. are on pace to sell a combined $2 billion of their new RSV ...
bloomberg.com/news/articles/2023-10-02/pfizer-gsk-rsv-shots-seen-nabbing-2-billion-in-sales-this-year
Chance discovery helps fight against malaria: Scientists have found a strain of bacteria which they believe could prevent spread of the disease.
bbc.com/news/health-66394117
Quick Glance: Chance Discovery Aids in Malaria Fight
- Researchers accidentally discover that a specific bacteria inhibits the development of malaria parasites in mosquitoes.
- The bacteria produces a molecule called harmane, which hinders the parasite's growth.
- This discovery offers new possibilities in combating one of the world's oldest diseases, claiming 600,000 lives annually.
- Experts view this new finding as promising.
GSK Invests €250 Million to Allow Freeze-Drying of Vaccines: GSK Plc will invest more than €250 million ($272 million) in a Belgian site for vaccines as the ...
bloomberg.com/news/articles/2023-08-30/gsk-invests-250-million-to-allow-freeze-drying-of-vaccines
Multinational companies’ exits mount pressure on NGX: In the last five months, three listed companies on the Nigerian Exchange have announced their plans to quit ...
punchng.com/multinational-companies-exits-mount-pressure-on-ngx/
Covid vaccine rollout begins early in the UK with new variant under watch: The National Health Service wants to avoid another "twindemic" of Covid and flu ...
cnbc.com/2023/09/11/uk-begins-covid-vaccine-rollout-early-with-new-variant-under-watch.html
Health Canada approves 1st RSV vaccine for older adults, drugmaker says: Health Canada has approved the RSV vaccine manufactured by GSK called Arexy for adults ...
globalnews.ca/news/9877917/health-canada-approves-1st-rsv-vaccine-for-older-adults-drugmaker-says/
Quick Glance: First RSV Vaccine Approved for Seniors in Canada
- Health Canada has granted approval for the first vaccine targeting respiratory syncytial virus (RSV) in adults aged 60 and above.
- The manufacturer GSK announces the approval of its new vaccine, named Arexvy, by the federal agency.
- Medical professionals have long advocated for an RSV vaccine designed specifically for seniors due to their heightened vulnerability to severe illness and hospitalization.
- Based on a randomized clinical trial, GSK reports that the vaccine demonstrates an 82 percent effectiveness in preventing RSV-induced lower respiratory tract disease among seniors compared to those who received a placebo.
Bacteria in mosquito guts trialled as weapon against malaria: Scientists hail ‘entirely novel approach’ to controlling a disease that kills more than 600 ...
ft.com/content/c4db7776-e776-4717-bf9d-7792d5ff0ad0
Paid articlePaid
Malaria deaths, cases reduce with vaccine and drug combination: Malaria deaths, cases reduce with vaccine and drug combination
nation.africa/kenya/health/malaria-deaths-cases-reduce-with-vaccine-and-drug-combination-4358448
FDA Approves RSV Vaccine to Pass Protection From Mother to Child: Doctors expect tens of thousands fewer infant hospitalizations because of new RSV tools.
wsj.com/health/pharma/rsv-vaccine-fda-pfizer-mother-child-bf7aaf24
The US eliminated malaria in 1951. How can it keep it under control now?: Working underground in a biosafety level 3 insectary in Tres Cantos, Madrid ...
cnn.com/2023/08/16/health/malaria-mosquito-control-scn/
Panel OKs 1st RSV Vaccine in Japan: TOKYO (Jiji Press) — A health ministry panel Monday agreed to approve a vaccine developed by GSK PLC to protect people from ...
japannews.yomiuri.co.jp/society/coronavirus/20230829-133002/
GSK’s departure from Nigeria will worsen poverty index – Peter Obi: The company announced plans to end its prescription medicines and vaccine production in the ...
punchng.com/gsks-departure-from-nigeria-will-worsen-poverty-index-peter-obi/
Malaria: bed nets, chemoprevention and vaccination prevent most diseases: London - The first malaria vaccine Mosquirix (RTS,S/AS01E), which the World Health ...
aerzteblatt.de/nachrichten/145502/Malaria-Bettnetze-Chemopraevention-und-Impfung-verhindern-die-meisten-Erkrankungen
GSK’s Nigerian Unit to Close Down, Return Cash to Shareholders: GlaxoSmithKline Consumer Nigeria Plc, the second-biggest drug producer in the West African nation ...
bloomberg.com/news/articles/2023-08-03/gsk-s-nigerian-unit-to-close-down-return-cash-to-shareholders
Quick Glance: GSK Nigeria ends operations and returns cash
- GSK Nigeria plans to cease distribution of its drugs and transition to a third-party model.
- Parent company GSK will reduce operations in Africa and adopt a distributor-led approach.
- GSK Nigeria is working with advisors to plan next steps and submit a cash return proposal to shareholders.
- The decision to cease operations was made by the board of GSK Nigeria after evaluating various options.
GSK: Experts fear more coys may exit Nigeria: Operators have expressed fears of more foreign companies leaving the country, following the recent announcement of ...
punchng.com/gsk-experts-fear-more-coys-may-exit-nigeria/
Dramatic reductions in malaria cases and deaths continue over five years with seasonal malaria vaccine-drug combination
medicalxpress.com/news/2023-08-reductions-malaria-cases-deaths-years.html
Fed’s Powell Will Walk an Economic Tightrope. Why Markets May Not Like It.: Retailers’ earnings will show how eagerly consumers are spending, J&J spinoff Kenvue ...
barrons.com/articles/what-to-know-today-4e5b91ef
Paid articlePaid UK health regulator approves GSK's vaccine for common respiratory virus RSV: Britain's health regulator approved GSK's (GSK.L) vaccine for the respiratory ...
reuters.com/business/healthcare-pharmaceuticals/uk-regulator-authorizes-gsks-rsv-vaccine-2023-07-10/
Quick Glance: GSK's Vaccine for RSV Virus Approved by UK Health Regulator
- GSK's Arexvy shot has been authorized by the MHRA for active immunization against RSV-induced lower respiratory tract disease in adults aged 60 and older.
- Efforts to develop a successful vaccine against RSV have been hindered by the virus's complex molecular structure and safety concerns with previous vaccine attempts since its discovery in 1956.
GSK: Govt urged to engage multinationals: Some economic experts have urged the Federal Government to engage the executives of multinational companies in the ...
punchng.com/gsk-govt-urged-to-engage-multinationals/
TB vaccine candidate to enter final trial, raising hopes of saving millions: If the next steps are successful, M72 would be the first new vaccine in a century to ...
washingtonpost.com/wellness/2023/06/30/tuberculosis-vaccine-trial-funding-gates/
Quick Glance: TB vaccine candidate in final trial, raising hopes of saving millions
- Efforts to end the tuberculosis pandemic may get a boost as a promising vaccine candidate secures funding for Phase III trials.
- The M72 vaccine could be the first new tuberculosis vaccine in a century if successful in the next trials and approved by regulators.
- Tuberculosis infected over 10 million people in 2021, mainly in low- and middle-income countries.
- Proof-of-concept trials showed that the M72 vaccine could prevent pulmonary disease in 54 percent of TB-infected adults.
Private sector urges FG to stop companies’ shutdowns: The Organised Private Sector has expressed worry that the recent exit of GlaxoSmithKline could trigger a ...
punchng.com/private-sector-urges-fg-to-stop-companies-shutdowns/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics